pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›SCOPOLAMINE
drug
save

SCOPOLAMINE

Marketedupdated 3mo ago
by Rhodes Pharmaceuticals LP
Approved
community read0 votes

🐶 often sniffed alongside

top 3
  • tagApproval16 co-mentions · 8 sources
  • drugscopolamine ER8 co-mentions · 8 sources
  • companyRiconpharma LLC4 co-mentions · 4 sources

all catalysts(0)

nothing on the calendar yet

Trials studying SCOPOLAMINE

  • phase1PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptorwithdrawn
  • phase2Efficacy and Safety of Escócia Association in the Treatment of Acute Painwithdrawn

News(0)

no news has mentioned this drug yet

brand
SCOPOLAMINE
generic
SCOPOLAMINE
indication
Emesis (Vomiting)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?